SHH · 603259.SS
WuXi AppTec Co., Ltd.
CN¥142.01-CN¥0.88 (-0.62%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.2% below the high.
Loading market information…
HKSE · 1833.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:22 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Ping An Healthcare and Technology Company Limited’s quoted price sits in the lower half of its reported 52-week range, 71.15% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Ping An Healthcare and Technology Company Limited’s next earnings report is currently expected on Mar 16, 2027, with estimated earnings per share of -HK$0.08. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Ping An Healthcare and Technology Company Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Ping An Healthcare and Technology Company Limited (PAHT), through its subsidiaries, operates a comprehensive online platform that delivers healthcare services across the People's Republic of China. Its core offerings encompass virtual medical consultations, facilitated hospital referrals and appointment scheduling, inpatient care coordination, and expert second opinions. PAHT also provides standardized consumer healthcare packages, integrating services from a network of medical institutions. Beyond services, the company offers a broad array of products, including pharmaceuticals, health supplements, medical devices, wellness items such as fitness equipment and personal care products, and other miscellaneous goods. Furthermore, PAHT engages users with health management and wellness interaction services, featuring various programs, interactive tools, activities, and personalized content. Its additional operations include medicine marketing, technology services, application development and maintenance, direct hospital and clinic services, and the management of an insurance agency. Established in 2014, Ping An Healthcare and Technology Company Limited maintains its headquarters in Shanghai, China.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:37 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| HK$2.25B |
| Q4 2023 | Mar 19, 2024 | -HK$0.03+65.0% vs estimate | HK$2.70B-17.2% vs estimate |
|---|
| Q2 2023 | Aug 24, 2023 | -HK$0.09+20.69% vs estimate | HK$2.40B-22.03% vs estimate |
|---|
| Q4 2022 | Mar 13, 2023 | -HK$0.07+64.58% vs estimate | HK$3.77B+1.22% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥142.01-CN¥0.88 (-0.62%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.2% below the high.
CN¥48.46-CN¥0.16 (-0.33%)
Jiangsu Hengrui Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.39% below the high.
HK$50.80+HK$0.15 (+0.3%)
Jiangsu Hengrui Pharmaceuticals Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 37.25% below the high.
CN¥181.75+CN¥2.75 (+1.54%)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 19.04% below the high.
HK$38.24+HK$2.26 (+6.28%)
JD Health International Inc.’s quoted price sits in the lower half of its reported 52-week range, 46.67% below the high.
HK$2.83+HK$0.08 (+2.72%)
Alibaba Health Information Technology Limited’s quoted price sits in the lower half of its reported 52-week range, 64.22% below the high.
HK$3.09-HK$0.37 (-10.58%)
160 Health International Ltd.’s quoted price sits in the lower half of its reported 52-week range, 98.05% below the high.
HK$0.86-HK$0.02 (-2.27%)
Dingdang Health Technology Group Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.75% below the high.
